Form 4 for KVYO Klaviyo, Inc.
Accepted 2026-01-16 00:00:00 ET · period of report 2026-01-15 · accession 0001470831-26-000041 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-01-16 | 2026-01-15 | KVYO | Whalen Amanda | CFO | S - Sale | $25.83 | -14.0K | 442.2K | -3% | -$361.7K |
| D | 2026-01-16 | 2026-01-15 | KVYO | Whalen Amanda | CFO | C - Cnv Deriv | — | +4,045 | 456.2K | +0.9% | — |
| D | 2026-01-16 | 2026-01-15 | KVYO | Whalen Amanda | CFO | C - Cnv Deriv | $0.00 | -4,045 | 344.9K | -1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Series A Common Stock | 2026-01-15 | S | D | 7,826 | $26.08 | 448,393 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.78 to $26.73 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 2 | Common | Series A Common Stock | 2026-01-15 | C | A | 4,045 | — | 456,219 | D | — | — | (F2) Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. |
| 3 | Common | Series A Common Stock | 2026-01-15 | S | D | 6,174 | $25.52 | 442,219 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.295 to $25.68 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F5) Consists of (i) 42,687 shares of Series A Common Stock and (ii) 399,532 unvested restricted stock units ("RSUs") awarded under the Issuer's 2023 Stock Option and Incentive Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. |
| 4 | Derivative | Series B Common Stock | 2026-01-15 | C | D | 4,045 | $0.00 | 344,918 | D | — · — to — | 4,045 Series A Common Stock | (F6) Consists of (i) 235,543 shares of Series B Common Stock and (ii) 109,375 unvested RSUs awarded under the Issuer's 2015 Stock Incentive Plan, each representing the contingent right to receive one share of Series B Common Stock upon vesting and settlement. (F2) Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. |